cysteamine has been researched along with Atherogenesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, F; Houben, T; Leake, DS; Mitchell, RD; Palo, A; Parnell, AJ; Patel, K; Shiri-Sverdlov, R; Yadati, T | 1 |
| Ahmad, F; Leake, DS; Mohri, Z; Weinberg, PD; Wen, Y | 1 |
| Ahmad, F; Leake, DS | 1 |
| Du, F; Fan, D; Ma, L; Tong, C; Wu, Y; Xie, G; Xu, Y; Yu, H | 1 |
4 other study(ies) available for cysteamine and Atherogenesis
| Article | Year |
|---|---|
Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice.
Topics: Animals; Atherosclerosis; Cholesterol; Cysteamine; Drinking Water; Humans; Lipoproteins, LDL; Liver; Mice; Muscles; Receptors, LDL | 2021 |
Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.
Topics: Animals; Antioxidants; Aorta; Aortic Diseases; Atherosclerosis; Cysteamine; Disease Models, Animal; Female; Foam Cells; Humans; Hydrogen-Ion Concentration; Lipoproteins, LDL; Lysosomes; Mice, Knockout; Oxidation-Reduction; Plaque, Atherosclerotic; Receptors, LDL; Sphingomyelin Phosphodiesterase; THP-1 Cells | 2019 |
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
Topics: Animals; Antioxidants; Atherosclerosis; Cell Line; Ceroid; Chromatography, High Pressure Liquid; Cysteamine; Ferrous Compounds; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Lipoproteins, LDL; Lysosomes; Oxidation-Reduction; Probucol; Rabbits | 2018 |
PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.
Topics: Animals; Apolipoproteins E; Apoptosis; Aryldialkylphosphatase; Atherosclerosis; Cell Line; Cysteamine; Disease Models, Animal; Escherichia coli; HeLa Cells; Humans; Inflammation; Liver; Macrophages; Male; Methionine Sulfoxide Reductases; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptides; Protein Structure, Tertiary; Reactive Oxygen Species; Recombinant Fusion Proteins; Superoxide Dismutase | 2015 |